Month: February 2024

CARLSBAD, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $3.1 million, or $0.52 per diluted share, on net sales of $25.2 million for the second quarter of fiscal year 2024 compared to net income of $1.8 million, or $0.31 per diluted share, in the second quarter of the prior fiscal year. Net sales during the three months ended December 31, 2023, decreased $17.1 million, or 40%, to $25.2 million as compared to $42.3 million recorded in the comparable prior year period. During the same period, private-label contract manufacturing sales decreased 44% to $23.0 million. Private-label contract manufacturing sales decreased primarily due to reduced orders...

ARCHBOLD, Ohio, Feb. 13, 2024 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO) today reported financial results for the 2023 fourth quarter and twelve months ended December 31, 2023. 2023 Fourth Quarter Financial and Operating Highlights (on a year-over-year basis unless noted):83 consecutive quarters of profitability Net income was $5.5 million, or $0.41 per basic and diluted share Asset quality remains strong as nonperforming loans were 0.87% of total loans Net charge-offs to average loans were 0.03% Allowance for credit losses was 111.95% of nonperforming loans Tier 1 leverage ratio was 8.20% Opened first bank office in Michigan and new regional headquarters in Fort Wayne, Indiana Added Ian D. Boyce to the Board of Directors of both the Company and the Bank Realigned organizational structure to support...

HighlightsFourth quarter revenue of $2.6 billion; net income attributable to GXO of $73 million; adjusted EBITDA1 of $193 million; diluted EPS of $0.61 and adjusted diluted EPS1 of $0.70 Full year revenue of $9.8 billion; net income attributable to GXO of $229 million; adjusted EBITDA1 of $741 million; diluted EPS of $1.92 and adjusted diluted EPS1 of $2.59 Full year cash flows from operations of $558 million, equivalent to 244% of net income attributable to GXO, and free cash flow1 of $302 million, equivalent to 41% of adjusted EBITDA1 Announced 2024 guidance2:Organic revenue growth1 of 2%-5% Adjusted EBITDA1 of $760-$790 million Adjusted diluted earnings per share1 of $2.70-$2.90 Free cash flow conversion1 of 30%-40% of adjusted EBITDA1Business HighlightsSigned more than $1 billion annualized revenue in 2023; ~40% from outsourcing ~$600...